G. J. Poston, J. Figueras, F. Giuliante, G. Nuzzo, A. F. Sobrero et al., Urgent need for a new staging system in advanced colorectal cancer, J Clin Oncol, vol.26, pp.4828-4861, 2008.

C. De-divitiis, G. Nasti, M. Montano, R. Fisichella, R. V. Iaffaioli et al., Prognostic and predictive response factors in colorectal cancer patients: between hope and reality, World J Gastroenterol, vol.20, pp.15049-59, 2014.

G. P. Kanas, A. Taylor, J. N. Primrose, W. J. Langeberg, M. A. Kelsh et al., Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors, Clin Epidemiol, vol.4, pp.283-301, 2012.

E. Heitzer, P. Ulz, and J. B. Geigl, Circulating tumor DNA as a liquid biopsy for cancer, Clin Chem, vol.61, pp.112-135, 2015.

E. Crowley, D. Nicolantonio, F. Loupakis, F. Bardelli, and A. , Liquid biopsy: monitoring cancer-genetics in the blood, Nat Rev Clin Oncol, vol.10, pp.472-84, 2013.

C. Bettegowda, M. Sausen, R. J. Leary, I. Kinde, Y. Wang et al., Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014.

A. D. Nygaard, P. C. Holdgaard, K. Spindler, N. Pallisgaard, and A. Jakobsen, The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC, Br J Cancer, vol.110, pp.363-371, 2014.

K. Spindler, N. Pallisgaard, I. Vogelius, and A. Jakobsen, Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan, Clin Cancer Res, vol.18, pp.1177-85, 2012.

K. Spindler, A. L. Appelt, N. Pallisgaard, R. F. Andersen, I. Brandslund et al., Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer, Int J Cancer, vol.135, pp.2984-91, 2014.

S. Dawson, D. Tsui, M. Murtaza, H. Biggs, O. M. Rueda et al., Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013.

R. Sirera, R. M. Bremnes, A. Cabrera, E. Jantus-lewintre, E. Sanmartín et al., Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer, J Thorac Oncol, vol.6, pp.286-90, 2011.

C. Tissot, A. Toffart, S. Villar, P. Souquet, M. P. Moro-sibilot et al., Circulating free DNA concentration is an independent prognostic biomarker in lung cancer, Eur Respir J, vol.46, pp.1773-80, 2015.

E. Sunami, M. Shinozaki, C. S. Higano, R. Wollman, T. B. Dorff et al., Multimarker circulating DNA assay for assessing blood of prostate cancer patients, Clin Chem, vol.55, pp.559-67, 2009.

N. Singh, S. Gupta, R. M. Pandey, S. S. Chauhan, and A. Saraya, High levels of cellfree circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival, Cancer Invest, vol.33, pp.78-85, 2015.

G. Perkins, T. A. Yap, L. Pope, A. M. Cassidy, J. P. Dukes et al., MultiPurpose utility of circulating plasma DNA testing in patients with Advanced Cancers, PLoS ONE, vol.7, p.47020, 2012.

K. Jung, M. Fleischhacker, and A. Rabien, Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature, Clin Chim Acta, vol.411, pp.1611-1635, 2010.

D. Mattos-arruda, L. Olmos, D. Tabernero, and J. , Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer, Future Oncol, vol.7, pp.1385-97, 2011.

A. B. Philipp, P. Stieber, D. Nagel, J. Neumann, F. Spelsberg et al., Prognostic role of methylated free circulating DNA in colorectal cancer, Int J Cancer, vol.131, pp.2308-2327, 2012.

H. S. Lee, S. M. Hwang, T. S. Kim, D. Kim, D. J. Park et al., Circulating methylated septin 9 nucleic acid in the plasma of patients with gastrointestinal cancer in the stomach and colon, Transl Oncol, vol.6, pp.290-296, 2013.

I. Balgkouranidou, D. Matthaios, A. Karayiannakis, H. Bolanaki, P. Michailidis et al., Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients, Mutat Res, vol.778, pp.46-51, 2015.

N. Umetani, A. E. Giuliano, S. H. Hiramatsu, F. Amersi, T. Nakagawa et al., Prediction of breast tumor progression by integrity of free circulating DNA in serum, J Clin Oncol, vol.24, p.4270, 2006.

K. Chan, S. Leung, S. Yeung, A. Chan, and Y. Lo, Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients, Clin Cancer Res, vol.14, pp.4141-4146, 2008.

S. Iqbal, S. Vishnubhatla, V. Raina, S. Sharma, A. Gogia et al., Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer, Springerplus, vol.4, p.265, 2015.

F. Mouliere, E. Messaoudi, S. Pang, D. Dritschilo, A. Thierry et al., Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer, Mol Oncol, vol.8, pp.927-968, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01076572

A. R. Thierry, F. Mouliere, E. Messaoudi, S. Mollevi, C. Lopez-crapez et al., Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA, Nat Med, vol.20, pp.430-435, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02168071

S. El-messaoudi, F. Rolet, F. Mouliere, and A. R. Thierry, Circulating cell free DNA: preanalytical considerations, Clin Chim Acta, vol.424, pp.222-252, 2013.

D. Chen, J. Huang, K. Liu, L. Zhang, Y. Z. Chuai et al., BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis, PLoS ONE, vol.9, p.90607, 2014.

S. Dawson, D. Tsui, M. Murtaza, H. Biggs, O. M. Rueda et al., Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013.

F. Bidard, J. Madic, P. Mariani, S. Piperno-neumann, A. Rampanou et al., Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma, Int J Cancer, vol.134, pp.1207-1220, 2014.

X. Q. Chen, H. Bonnefoi, M. F. Pelte, J. Lyautey, C. Lederrey et al., Telomerase RNA as a detection marker in the serum of breast cancer patients, Clin Cancer Res, vol.6, pp.3823-3829, 2000.

A. I. Phipps, D. D. Buchanan, K. W. Makar, A. K. Win, J. A. Baron et al., KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers, Br J Cancer, vol.108, pp.1757-64, 2013.

A. Li-evre, J. Bachet, L. Corre, D. Boige, V. Landi et al., KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer, Cancer Res, vol.66, pp.3992-3997, 2006.

A. R. Thierry, F. Mouliere, C. Gongora, J. Ollier, B. Robert et al., Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Res, vol.38, pp.6159-75, 2010.

C. Rago, D. L. Huso, F. Diehl, B. Karim, G. Liu et al., Serial assessment of human tumor burdens in mice by the analysis of circulating DNA, Cancer Res, vol.67, pp.9364-70, 2007.

F. Mouliere, E. Messaoudi, S. Gongora, C. Guedj, A. et al., Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load, Transl Oncol, vol.6, pp.319-347, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00872683

F. Mouliere, B. Robert, A. Peyrotte, E. , D. Rio et al., High fragmentation characterizes tumour-derived circulating DNA, PLoS ONE, vol.6, 2011.

N. P. West, M. Dattani, P. Mcshane, G. Hutchins, J. Grabsch et al., The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients, Br J Cancer, vol.102, pp.1519-1542, 2010.

L. Marisa, A. De-reyni-es, A. Duval, J. Selves, M. P. Gaub et al., Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value, PLoS Med, vol.10, p.1001453, 2013.

D. J. Moore, A. Greystoke, F. Butt, J. Wurthner, J. Growcott et al., A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients, Clin Drug Investig, vol.32, pp.179-87, 2012.

C. Huang, M. Tsai, C. Hsu, H. Chen, T. Wang et al., Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients, Resuscitation, vol.83, pp.213-221, 2012.

J. A. Bufill, Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location, Ann Intern Med, vol.113, pp.779-88, 1990.

S. Y. Brul-e, D. J. Jonker, C. S. Karapetis, C. J. O'callaghan, M. J. Moore et al., Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17, Eur J Cancer, vol.51, pp.1405-1419, 2015.